The Tate Cancer Center at University of Maryland Baltimore Washington Medical Center opened in 2003 and is named for community philanthropists Creston and Betty Jane Tate. The center was a $17.4 million project that was completed to provide cancer patients with high-quality outpatient care conveniently located on the hospital’s campus, all under one roof.
- Accredited as an Academic Comprehensive Cancer Program (ACAD). ACADs are cancer centers that provide post graduate medical education, accession more than 500 newly diagnosed cancer patients each year, offer a full range of diagnostic and treatment services, and participate in cancer related clinical research. Only 13 percent of all cancer programs in the nation have achieved this status.
- Accredited by the American College of Surgeons Commission on Cancer, which aims to improve cancer patient care through nationally recognized programs.
- A member of The Alliance for Clinical Trials in Oncology, a national clinical trials network sponsored by the National Cancer Institute. The Alliance comprises nearly 10,000 cancer specialists at hospitals, medical centers and community clinics across the United States and Canada who offer their patients clinical trials for different types of cancer.
- The Aiello Breast Center, a partner of the Tate Cancer Center, was one of the first breast centers in Maryland to be accredited by the National Accreditation Program for Breast Centers (NAPBC), a program of the American College of Surgeons.
University of Maryland Cancer Network
The Tate Cancer Center is affiliated with the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), and is part of the University of Maryland Cancer Network. The Network provides access to national experts, the latest treatments, leading edge technology, and promising clinical trials — all close to home. Click here to learn more about the network.
Click here to view the Tate Cancer Center 's 2017 Annual Report.